HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients.

AbstractBACKGROUND AND OBJECTIVE:
Morphine dosing can be challenging in terminally ill adult patients due to the heterogeneous nature of the population and the difficulty of accurately assessing pain during sedation. To determine the pharmacokinetics of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) in this population, and to find clinically relevant parameters for dose individualisation, we performed a population pharmacokinetic analysis.
METHODS:
Blood samples were randomly collected from 47 terminally ill patients in both the pre-terminal and terminal phases. Nonlinear mixed-effects modelling (NONMEM) was used to develop a population pharmacokinetic model and perform covariate analysis.
RESULTS:
The data were accurately described by a two-compartment model for morphine with two one-compartment models for both its metabolites. Typical morphine clearance was 48 L/h and fell exponentially by more than 10 L/h in the last week before death. Decreased albumin levels and a decreased estimated glomerular filtration rate (eGFR) resulted in lower metabolite clearance. Between-subject variability in clearance was 52 % (morphine), 75 % (M3G) and 79 % (M6G), and changed to 53, 29 and 34 %, respectively, after inclusion of the covariates.
CONCLUSIONS:
Our results show that morphine clearance decreased up to the time of death, falling by more than 10 L/h (26 %) in the last week before death, and that M3G and M6G accumulated due to decreased renal function. Further studies are warranted to determine whether dose adjustment of morphine is required in terminally ill patients.
AuthorsLinda G Franken, Anniek D Masman, Brenda C M de Winter, Birgit C P Koch, Frans P M Baar, Dick Tibboel, Teun van Gelder, Ron A A Mathot
JournalClinical pharmacokinetics (Clin Pharmacokinet) Vol. 55 Issue 6 Pg. 697-709 (06 2016) ISSN: 1179-1926 [Electronic] Switzerland
PMID26715216 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Analgesics, Opioid
  • Morphine Derivatives
  • Serum Albumin
  • morphine-6-glucuronide
  • Morphine
  • morphine-3-glucuronide
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid (pharmacokinetics)
  • Computer Simulation
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Models, Biological
  • Morphine (pharmacokinetics)
  • Morphine Derivatives (pharmacokinetics)
  • Prospective Studies
  • Serum Albumin
  • Terminally Ill

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: